Diabetic retinopathy remains a major cause of vision loss among working-age individuals worldwide. While chronic ...

In a separate study, an implant containing a different investigational endothelin antagonist (PER-001) reduced macular ...

PER-001, delivered through a slow-release, dissolvable implant in the vitreous cavity of the eye, is designed to block ...

Exonate has announced plans to initiate a phase 2b clinical trial of its lead candidate EXN407, a topical SRPK1 inhibitor, ...

USA: A new study has found that survival models using electronic health record (EHR) data can accurately predict the ...

Cannabis use disorder (CUD) is associated with increased risk of benign salivary gland tumors, according to a research letter published online July 17 in JAMA Otolaryngology-Head & Neck Surgery.

Ciprofol, an innovative anesthetic derived from propofol, has not yet been studied in detail regarding its effects in colorectal cancer (CRC). This study mainly explored the effects of Ciprofol on the ...

A study published in the journal Phytomedicine “provides the first evidence that CBD inhibits osteosarcoma [a highly ...

Diabetic retinopathy (DR) is a leading cause of vision loss in patients with diabetes, with limited therapeutic options. While current treatments focus on the proliferative stage, there is an urgent ...

ICAM2 (CD102) was significantly elevated in serum and renal tissue of proliferative LN and was associated with specific pathological attributes, outperforming conventional parameters in distinguishing ...

Proliferative glomerulonephritis with monoclonal immunoglobulin deposition (PGNMID) is a rare variant of monoclonal gammopathy of renal significance (MGRS). Although the pathogenesis of PGNMID is not ...